Abstract
Ulcerogenesis of the duodenal mucosa frequently involves an inflammatory reaction with infiltration of leukocytes. Measurement of neutrophil myeloperoxidase activity might thus be a sensitive indicator of damage, before visible lesions occur. To test this possibility, a rat model for duodenal injury was used where fasted animals were treated with indomethacin and histamine-diHCl. Twenty-four hours after indomethacin treatment, duodenal tissues were collected for histochemical staining and biochemical assay for myeloperoxidase activity. Indomethacin- and histamine-challenged rats had significantly elevated myeloperoxidase activity compared to unchallenged controls (P < 0.05) for both histochemistry and biochemistry. There was also a significant correlation between these two parameters (r=0.68, P < 0.001). The duodenal injury model then was used to test the effectiveness of known gastric protective agents. Results indicated that milk and buttermilk did not aggravate or protect against duodenal injury, while antacid and prostaglandin did significantly protect against inflammation (P < 0.02). We concluded that measurement of myeloperoxidase activity is a sensitive and potentially useful estimate of duodenal injury that can be valuable in assessing ulcerogenesis and healing.
Similar content being viewed by others
References
Kurata JH, Haile BM, Elashoff JD: Sex differences in peptic ulcer disease. Gastroenterology 88:96–100, 1985
Cutin J, Haase H, Moura MA: Evaluation of electrical potential difference across gastric mucosa in patients with chronic gastritis according to site, histology and degree of inflammation. Dig Dis Sci 32:239–243, 1987
Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87:1344–1350, 1984
Bos A, Wever R, Roos D: Characterization and quantification of the peroxidase in human monocytes. Biochim Biophys Acta 525:37–44, 1978
Szabo S, Horner HC, Gallagher GT: Drug-induced duodenal ulcer: Structure-activity correlations and pathogenesis.In Drugs and Peptic Ulcer. CJ Pfeiffer (ed). Boca Raton, CRC Press, 1982, pp 55–74
Szabo S: Biology of disease. Pathogenesis of duodenal ulcer disease. Lab Invest 51:121–147, 1984
Takeuchi K, Furukawa O, Tanaka H, Okabe S: A new model of duodenal ulcers induced in rats by indomethacin plus histamine. Gastroenterology 90:636–645, 1986
Smith JW, Castro GA: Relation of peroxidase activity in gut mucosa to inflammation. Am J Physiol 234:R72-R79, 1978
Castro GA, Roy SA, Stockstill RD:Trichinella spiralis: Peroxidase activity in isolated cells from the rat intestine. Exp Parasitol 36:307–315, 1974
Patriarca P, Cramer R, Marussi M, Rossi F, Romeo D: Mode of activation of granule-bound NADPH oxidase in leukocytes during phagocytosis. Biochim Biophys Acta 237:335–338, 1971
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin-phenol reagent. J Biol Chem 193:265–275, 1951
Whittle BJR: Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 80:94–98, 1981
Hawkey CJ, Rampton DS: Prostaglandins and the gastrointestinal mucosa: Are they important in its function, disease, or treatment? Gastroenterology 89:1162–1188, 1985
Miller TA: Protective effects of prostaglandins against gastric mucosal damage: Current knowledge and proposed mechanisms. Am J Physiol 245:G601-G623, 1983
Robert A, Nezamis JE, Lancaster C, Badalamenti JN: Cysteamine-induced duodenal ulcers: A new model to test antiulcer agents. Digestion 11:199–214, 1974
Szelenyi I, Postius S, Engler H: Evidence for a functional cytoprotective effect produced by antacids in the rat stomach. Eur J Pharmacol 88:403–406, 1983
Szelenyi I, Postius S: Further evidence for gastroprotection induced by aluminum hydroxide in the rat. Z Gastroenterol 24:717–721, 1986
Berstad A, Rydning A, Aadland E, Kolstad B, Frislid K, Aaseth J: Controlled clinical trial of duodenal ulcer healing with antacid tablets. Scand J Gastroenterol 17:953–959, 1982
Lam SK, Lam KC, Lai CL, Yeung CK, Yam LYC, Wong WS: Treatment of duodenal ulcer with antacid and sulpiride. Gastroenterology 76:315–322, 1978
Preclick G, Stange EF, Gerber K, Fetzer G, Horn H, Ditschuneit H: Stimulation of mucosal prostaglandin synthesis in human stomach and duodenum by antacid treatment. Gut 30:148–151, 1989
DiJoseph JF, Borella LE, Mir GN: Activated aluminum complex derived from solubilized antacids exhibits enhanced cytoprotective activity in the rat. Gastroenterology 96:730–735, 1989
Szabo S, Mozsik G: New Pharmacology of Ulcer Disease. New York, Elsevier, 1987
McDonald CA, Goulston KJ: Effect of paracetamol and milk on aspirin-induced gastric erosions in man. Aust NZ J Med 13:439, 1983
Sippy BW: Gastric and duodenal ulcer. JAMA 64:1625–1630, 1915
Sandweiss DJ: The Sippy treatment for peptic ulcer—fifty years later. Am J Dig Dis 6:929–937, 1961
Spiro HM: Is milk all that bad for the ulcer patient? J Clin Gastroenterol 3:219–220, 1981
Lennard-Jones JE, Babouris N: Effect of different foods in the acidity of the gastric contents in patients with duodenal ulcer. Part 1. A comparison between two “therapeutic” diets and freely-chosen meals. Gut 6:113–117, 1965
Doll R, Friedlander P, Pygott F: Dietetic treatment of peptic ulcer. Lancet 1:5–9, 1956
Dial EJ, Lichtenberger LM: A role of milk phospholipids in protection against gastric acid. Studies in adult and suckling rats. Gastroenterology 87:379–385, 1984
Dial EJ, Lichtenberger LM: Milk protection against experimental ulcerogenesis in rats. Dig Dis Sci 32:1145–1150, 1987
Materia A, Jaffe BM, Money SR, Rossi P, DeMarco M, Basso N: Prostaglandins in commercial milk preparations. Arch Surg 119:290–292, 1984
Watson LC, Abston S: Prevention of upper gastrointestinal hemorrhage in 582 burned children. Am J Surg 132:790–793, 1976
Ippolitti AF, Maxwell V, Isenberg JI: The effect of various forms of milk on gastric acid secretion. Ann Intern Med 84:286–289, 1976
Levant JA, Walsh JH, Isenberg JI: Stimulation of gastric secretion and gastrin release by single oral doses of calcium carbonate in man. N Engl J Med 289:555–558, 1973
Debas HT, Walsh JH, Grossman MI: Release of antral gastrin by large polypeptides. Clin Res 22:171A, 1974
Walsh JH, Richardson CT, Fordtran JS: pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 55:462–468, 1975
Orrenius S, Nicotera P: On the role of calcium in chemical toxicity. Arch Toxicol Suppl 11:11–19, 1987
Jones DP, McConkey DJ, Nicotera P, Orrenius S: Calciumactivated DNA fragmentation in rat liver nuclei. J Biol Chem 264:6398–6403, 1989
Critchlow J, Magee D, Ito S, Takeuchi K, Silen W: Requirements for restitution of the surface epithelium of frog stomach after mucosal injury. Gastroenterology 88:237–249, 1985
Author information
Authors and Affiliations
Additional information
This work was supported by grants from Wisconsin Milk Marketing Board and National Institutes of Health (DK33239).
Rights and permissions
About this article
Cite this article
Cooper, L.C., Dial, E.J. & Lichtenberger, L.M. Effects of milk, prostaglandin, and antacid on experimentally induced duodenitis in the rat. Digest Dis Sci 35, 1211–1216 (1990). https://doi.org/10.1007/BF01536409
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01536409